Heartland Advisors Inc. Acquires New Stake in Core Laboratories Inc. $CLB

Heartland Advisors Inc. acquired a new stake in shares of Core Laboratories Inc. (NYSE:CLB) in the first quarter, HoldingsChannel.com reports. The firm acquired 150,000 shares of the oil and gas company’s stock, valued at approximately $2,518,000.

Other institutional investors also recently bought and sold shares of the company. Summit Securities Group LLC bought a new stake in shares of Core Laboratories during the 1st quarter valued at about $31,000. Aster Capital Management DIFC Ltd bought a new position in shares of Core Laboratories in the 4th quarter worth approximately $34,000. CWM LLC lifted its stake in shares of Core Laboratories by 36.1% in the 4th quarter. CWM LLC now owns 2,516 shares of the oil and gas company’s stock worth $40,000 after purchasing an additional 668 shares during the period. Quarry LP lifted its stake in shares of Core Laboratories by 118.1% in the 3rd quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock worth $36,000 after purchasing an additional 1,599 shares during the period. Finally, Hantz Financial Services Inc. boosted its holdings in shares of Core Laboratories by 124.7% in the fourth quarter. Hantz Financial Services Inc. now owns 3,177 shares of the oil and gas company’s stock worth $51,000 after buying an additional 1,763 shares during the last quarter. Institutional investors own 97.81% of the company’s stock.

Core Laboratories Price Performance

Shares of NYSE:CLB opened at $11.31 on Monday. The company has a market capitalization of $521.59 million, a P/E ratio of 17.41, a P/E/G ratio of 2.74 and a beta of 1.00. Core Laboratories Inc. has a 1-year low of $9.72 and a 1-year high of $20.36. The firm’s 50 day simple moving average is $12.51 and its two-hundred day simple moving average is $15.66. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.05 and a quick ratio of 1.50.

Core Laboratories (NYSE:CLB) last announced its quarterly earnings data on Wednesday, April 29th. The oil and gas company reported $0.06 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.06. The firm had revenue of $121.80 million during the quarter, compared to analysts’ expectations of $122.99 million. Core Laboratories had a net margin of 5.94% and a return on equity of 11.52%. The company’s revenue for the quarter was down 1.4% compared to the same quarter last year. During the same period in the prior year, the company posted $0.14 earnings per share. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS. Research analysts expect that Core Laboratories Inc. will post 0.53 EPS for the current fiscal year.

Core Laboratories Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Monday, May 11th were issued a $0.01 dividend. The ex-dividend date of this dividend was Monday, May 11th. This represents a $0.04 annualized dividend and a yield of 0.4%. Core Laboratories’s dividend payout ratio is currently 6.15%.

Wall Street Analyst Weigh In

A number of analysts have commented on CLB shares. Wall Street Zen cut shares of Core Laboratories from a “hold” rating to a “sell” rating in a report on Saturday, July 4th. Weiss Ratings cut shares of Core Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, June 24th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Core Laboratories has an average rating of “Reduce”.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.